Latest News and Updates
Nominations now open for ISH 2024 awards
17 April 2024: Nominations for ISH awards for 2024 are now open.
Awards will be presented at our upcoming Scientific Meeting in Cartagena, Colombia from 19 to 22 September 2024.
The deadline is 31 May 2024.
Celebrate World Hypertension Day
10 April 2024: As we approach World Hypertension Day on 17 May, visit our dedicated web pages for the 2024 campaign for ideas on how to get involved with the campaign and to support it.
In focus: Iraqi Hypertension Society
8 April 2024: In a short feature highlighting activity from an ISH-affiliated society, we look ahead to plans from the Iraqi Hypertension Society (IqHS) in 2024.
Professor George Stergiou confirmed as President Elect of the ISH
22 March 2024: Professor George Stergiou will be the next President of the International Society of Hypertension (2024-2026). President-Elect Professor Stergiou will take up the Presidential office at the conclusion of the ISH 2024 meeting in Cartagena in September 2024, succeeding the current President, Professor Bryan Williams.
Membership changes – announcement from the ISH Membership Chair
19 March 2024: Débora Colombari (Chair ISH Membership Committee) announces several changes to the ISH membership structure to make ISH membership more accessible around the world and improve member experience overall.
Changes include a new and simplified set of membership categories, and reduced and free memberships for some parts of the world, as well as the launch of a new and refreshed membership portal.
Initiative endorsed by the ISH launched in Thailand to improve hypertension care
18 March 2024: A new initiative to improve hypertension care in Thailand began this month.
Hypertension Camp – organised by the Thai Hypertension Society (THS) and endorsed by the ISH – will train 80 GPs and internal medicine doctors in Thailand in hypertension screening and management over the next two years.
‘Poorly controlled blood pressure is the most important factor contributing to loss of kidney function in established kidney disease’
14 March 2024: On World Kidney Day 2024, nephrology and hypertension specialist and ISH member Erika Jones writes about the link between hypertension and kidney disease, steps patients can take to help manage the conditions, and the importance of clinicians remaining up to date in the care of people with high blood pressure and kidney disease.
New resources launched by HEARTS programme in the Americas to support hypertension management
11 March 2024: Two new open-access publications have been launched to support primary health care teams in managing hypertension and cardiovascular risk effectively.
ISH part of 18th Indonesian Society of Hypertension Scientific Meeting 2024
6 March 2024: The ISH was delighted to be part of the 18th Indonesian Society of Hypertension (InaSH) Scientific Meeting 2024 at the end of February.
Paper highlights initiative to combat hypertension in Africa
12 February 2024: A paper published in the February issue of The Lancet Global Health outlines the work of the Accelerating African Control of Hypertension through Innovative Epidemiology and a Vibrant Ecosystem (ACHIEVE) initiative. ISH President Bryan Williams is one of the authors.
New report aims to improve adherence to blood pressure treatment
31 January 2024: The ISH is pleased to support the launch of a new report which aims to improve adherence to treatment for high blood pressure.
HEARTS initiative in the Americas improving hypertension control rates
6 January 2024: A new paper has outlined how the ‘HEARTS in the Americas’ programme is improving hypertension control rates across Latin America and the Caribbean.
ISH President recognised in the King’s New Year Honours in UK
4 January 2024: Congratulations to ISH President Bryan Williams who has been awarded an OBE for services to medicine in the King’s New Year Honours List 2024 in the UK.
December 2023 edition of Hypertension News out now
13 December 2023: Read the latest edition of Hypertension News which contains articles on: perspectives on recent hypertension studies; new systems of care for hypertension; perspectives on single pill therapy around the world; screening for high blood pressure in children and adolescents; and more.
Universal Health Coverage Day
12 December 2023: The ISH supports the campaign for Universal Health Coverage. This Universal Health Care Day, we urge leaders to invest in resilient and equitable health systems.
Early Bird Registration for ISH2024 Closes on 14 December 2023
11 December 2023: Don’t forget to register for the ISH2024 meeting at the Early Bird Rate which ends on 14 December 2023.
ISH launches new initiative to support early to mid-career researchers
27 November 2023: A new ISH initiative launched today will offer career development and networking opportunities for early and mid-career researchers and those from under-represented backgrounds.
Join the Second Edition of the International Certificate Hypertension Course for Latin America
The International Society of Hypertension Americas Regional Advisory Group (ISH RAG) and the Argentinean Society of Hypertension (SAHA) proudly present the second edition of the International Certificate Hypertension Course.
ISH e-Bulletin – October 2023 issue
The October 2023 e-Bulletin is now available. This issue is full of Society and partner news, with an introduction from the ISH Secretary Prof. George Stergiou.
September 2023 issue of the ISH publication Hypertension News
The September 2023 issue of the ISH publication Hypertension News is now available. Read articles about: A new ISH position paper on lifestyle changes and hypertension; high blood pressure in the young, use of potassium-enriched salt to lower blood pressure; inflammatory mechanisms of hypertension; the problem of ‘diagnostic inertia’; the ESH guidelines, a visit to the ISH2024 conference venue; a special series of articles on Latin America; and much more!
ISH e-Bulletin – September 2023 issue
The September 2023 e-Bulletin is now available. This issue is full of Society and partner news, with an introduction from the ISH Secretary Prof. George Stergiou.
Large study confirms no difference between bedtime and morning dosing of blood pressure medication
The time of day a patient takes medication for their high blood pressure makes no difference to how well the medication works, according to a large observational study led by an international team of researchers from Spain and the UK.
It is the biggest study to date addressing the question of timing of blood pressure medication.
Online tool launched to help patients manage their blood pressure at home
A new online course to help patients measure their blood pressure at home has been launched.
The ISH is one of seven hypertension organisations around the world to sponsor the interactive ‘Home Blood Pressure Monitoring: Promoting Patient Self-Measurement’ course, from the Pan American Health Organization (PAHO) and World Health Organisation (WHO).
ISH response to WHO report on the devastating impact of hypertension and ways to stop it
19 September 2023: The President of the ISH has responded to the publication of a new report by the World Health Organization (WHO) and Resolve to Save Lives on the devastating global impact of high blood pressure, along with recommendations on the ways to win the race against this silent killer.
New directions in management of high blood pressure – position paper from the ISH
15 September 2023: The latest ISH position paper – a comprehensive review of lifestyle changes that can help prevent and manage high blood pressure – is published today.
For the position paper, the ISH convened an international panel of experts from 18 countries to make recommendations on effective lifestyle changes for blood pressure control, based on the latest clinical and scientific evidence.
$10,750 donated to ISH by ReCor Medical
13 September 2023: The ISH is grateful to announce a donation of $10,750 (US dollars) from the company ReCor Medical, who raised the money through a company-wide initiative called “ReCor on the Move.”
Campaign to increase hypertension awareness in Nigeria making an impact with the help of volunteers trained by the ISH
Hundreds of people in Nigeria were screened for high blood pressure between May and August 2023 as part of a campaign which is being delivered with the help of volunteers trained by the ISH.
How global organisations working together will be instrumental in tackling the burden of hypertension
A new paper outlines how a collaboration between the WHO and global organisations including the ISH – the HEARTS partner forum – is leading the fight to improve the detection, treatment and control of high blood pressure around the world.
Report calls for action to improve circulatory health worldwide
A position paper co-authored by members of the ISH has highlighted what health systems and governments need to do to improve circulatory health worldwide.
24-hour measurement of blood pressure five times more informative of risk of death than conventional clinic blood pressure
In the largest ever study of its kind, 24hr ambulatory blood pressure monitoring was shown to be five times more informative regarding future mortality from cardiovascular and all cause mortality when compared to conventional clinic blood pressure measurement, according to research led by a research consortium from Spain, University of Oxford and University College London.
8 out of 10 blood pressure monitors for sale online not tested for accuracy
Around 8 in 10 of the best-selling blood pressure monitors online have not been validated for accuracy, a new analysis of devices available in ten countries indicates.
UK statistics highlight high rates of undiagnosed hypertension
‘Considerable numbers’ of young people in England have undiagnosed hypertension, according to data from the Office of National Statistics (ONS) in the UK.
Innovative study shows potential for personalised blood pressure treatment
There is large variation in how patients with hypertension respond to different blood pressure lowering drugs, according to a new study which highlights the potential for personalised treatment of high blood pressure.
ISH Women in Hypertension Research Committee highlight how to improve care for women with hypertension around the world
In a comprehensive review of hypertension in women, researchers have highlighted knowledge gaps in the field, and the lack of consideration of female-specific risk factors for hypertension in clinical guidelines.
The review paper, which originated from members of the ISH Women in Hypertension Research Committee (ISH-WiHRC) and is published this month in Hypertension, sets out what should be done to address these issues so that care for women with high blood pressure can be improved.
Health workers from across Africa trained and mentored in ISH initiative
94 health workers from across Africa have received training and mentorship as part of a new ISH initiative aimed at improving hypertension care across the continent.
The African School of Hypertension for Non-Physician Health Workers was set up by the ISH Africa Regional Advisory Group (RAG) and offers training on diagnosing and managing hypertension, and on referring patients to specialist physicians.
Course leaders pictured from left: Prof. Augustine Odili, Dr Adeseye Akintunde, Dr Godsent Isiguzo
Joint statement on the assessment of salt intake in research
The ISH, World Hypertension League and Resolve to Save Lives have published a consensus statement strongly recommending against conducting, funding or publishing research studies that use spot urine samples with estimating equations to assess individuals’ sodium (salt) intake in association with health outcomes.
The consensus statement was published in the Journal of Hypertension.
500,000 in UK missed out on blood pressure lowering drugs during pandemic
Nearly half a million people in England, Scotland and Wales missed out on starting medication to lower their blood pressure during the Covid-19 pandemic, according to new research published last night.
Responding to the research, President of the International Society of Hypertension, Professor Bryan Williams, said the data shows the potential impact of the pandemic on disruption to routine disease prevention, adding that patients shouldn’t need to visit doctors to get their blood pressure checked and their treatment dispensed.
International Consensus on Standardized Clinic Blood Pressure Measurement – A Call to Action
High blood pressure (BP) is the single leading risk factor for cardiovascular disease worldwide, and BP lowering substantially reduces that risk. Effective BP management relies on accurate measurement. This joint statement from 13 scientific health organizations around the globe (including the International Society of Hypertension) has the focused goal of emphasizing the importance of, and introducing a pragmatic approach to, standardized clinic BP measurement implemented in clinical practice.
ISH2022KYOTO Hypertension Zero Declaration
The ISH2022KYOTO Hypertension Zero Declaration was signed by Professors Hiroshi Itoh (Chair, ISH Kyoto 2022 Meeting) and Maciej Tomaszewski (ISH President 2020-2022) during the Closing Ceremony on 16th October 2022 and published online as a co-publication between Cardiovascular Research and Hypertension Research on 27th October 2022.
Addressing global disparities in blood pressure control: perspectives of the International Society of Hypertension
Raised blood pressure (BP) is the leading cause of preventable death in the world. Yet, its global prevalence is increasing, and it remains poorly detected, treated, and controlled in both high- and low-resource settings. From the perspective of members of the International Society of Hypertension based in all regions, we reflect on the past, present, and future of hypertension care, highlighting key challenges and opportunities, which are often region-specific.
Renin-Angiotensin System Inhibitors in Patients With COVID-19: A Meta-Analysis of Randomized Controlled Trials Led by the International Society of Hypertension
Renin-Angiotensin System Inhibitors in Patients With COVID-19: A Meta-Analysis of Randomized Controlled Trials Led by the International Society of Hypertension J Am Heart Assoc. 2022;11(17):e026143. doi: 10.1161/JAHA.122.026143.
This metanalysis demonstrates the safety of using renin-angiotensin system inhibitors in COVID-19.